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Most T  lymphocytes are not activated by antigen (Ag) 1 alone but recognize Ag in 
association with major histocompatibility complex (MHC)  gene products (1-4). This 
recognition occurs through a clonally distributed receptor(s) whose presence is inferred 
from the specific activation requirements of the T  lymphocyte. For the Ia-restricted 
T  cell this recognition requires an antigen-presenting cell  (APC) (4). Additionally, the 
ability  to  generate  T  cell-dependent  responses  to  protein  and  polypeptide  Ag  is 
determined by MHC-encoded Ir genes, which are intimately involved in this process 
of MHC-restricted recognition (5, 6). There is conclusive evidence that Ia molecules, 
which restrict the recognition of nominal AG, are Ir gene products (7-12). 
While the phenomenology of H-2-restricted recognition of Ag is well established, 
the  underlying mechanisms are  not  understood.  Specifically,  the  precise  nature  of 
both the T  cell  receptor(s)  and its  Ag and MHC ligand(s)  as well as the basis of Ir 
gene  unresponsiveness  is  not  known.  Numerous  theories  have  been  advanced  that 
raise most of the possible permutations, from a single receptor with linked ligands to 
dual receptors with unlinked ligands, but experimental verification is largely lacking 
(13-21).  Elegant somatic cell hybridization experiments by Kappler et /tl. (22) have 
strongly suggested that  restricted  recognition is  not  mediated by independent  dual 
receptors in conjunction with unlinked antigen and Ia molecules. There is increasing 
evidence for some form of interaction  between  Ag and Ia molecules.  Thus,  Ir gene 
products appear to select  the antigenic determinants to which a response is generated 
(23-25). Heber-Katz et al. (26) have clearly shown that the fine specificity of a single 
T  cell clone's activation is determined by the accessory ceils' MHC genotype, which 
strongly suggests an interaction between nominal Ag and MHC molecules. However, 
the nature of such an interaction is unknown. One possibility is that the interaction 
between nominal Ag and the accessory cell is specific. It is clear that Ir gene control 
discriminates antigenic differences as small as a  single amino acid (25).  In addition, 
structurally related Ag that elicit a clonally distinct T  cell  response appear to follow 
identical Ir gene control (27, 28). Accordingly we proposed a model where Ia molecules 
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40  60  40  l0  60  40  alanine  ; GAT, L-glutamic  acid -L-alanine -L-tyrosine ; GL, L-glutamic  acid -L-lysine ; GT, L-glutamic 
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TABL~  I 
Origin and Specificity of T Cell Hybridomas 
1619 
Origin  I region re-  Antigen spec-  Reference 
Hybrid  strietion  ificity 
T cell blast × tumor* 
RF7.24.3  BALB/c × BW5147  ]-A  d  GAT  30 
RF9.140  BALB/c × BW5 I47  I-A  a  GAT  This paper 
RFt0.14  BALB/c × BWM47  I-A  a  GAT  30 
RF15.7  BALB/c × BW5147  I-A  a  TNP  This paper 
RF13.64  B10 × BW5147  I-A  b  GAT  30 
DO11.10  BALB/c × BW5147  I-A  d  OVA  47 
AODK10.4  B10.D2 × AO40.10AG1  I-A  a  KLH  22 
* AO40.10AG1 is a double T cell hybridoma produced by the fusion of B10.A T cells with FS614.13, a 
B6D2Fa × BW5147 hybrid. 
can specifically associate with Ag via a  finite number of binding sites that recognize 
short amino acid sequences (29). Alternatively, the interaction could be general, e.g., 
via protein-protein interactions between nominal Ag and Ia molecules perhaps upon 
apposition  by  the  T  cell  receptor(s).  The  available  evidence  however,  does  not 
discriminate between these possibilities. 
A unique prediction of the specific association model is that distinct Ag, which use 
the same interaction site, should compete for association and subsequent presentation 
under limiting conditions. During the course of studies characterizing a  series of Ag- 
specific Ia-restricted T  cell hybridomas we observed a  specific competition between 
structurally related copolymers under Ir gene control. The analysis of this phenomenon 
is the subject of this report. 
Materials and Methods 
Mice.  BALB/cAnN mice,  2 ages  6-10 wk,  were  purchased  from Charles River Breeding 
Laboratories, Inc., Kingston, NY. C57BL/10, C57BL/6, CBFz, and BDFz mice, ages 5-7 wk, 
were purchased from The Jackson  Laboratory, Bar Harbor,  ME.  D2GD mice were kindly 
provided by Dr. M. Doff, Harvard Medical School. 
60  80  10  Antigens.  The random copolymers L-glutamic acid  -t-alanine -L-tyrosine  (GAT) (Vega 
Biochemicals,  Tucson, AZ)  tool  wt  30-50,000;  L-glutamic acidS°-L-tyrosine  ~°  (GT)  tool  wt 
--t30,000 (Lot 9) or 55,300  (Lot  10); L-g]utamic acid~°-L-alanine  *° (GA) tool-wt --360,000; L- 
glutamic acidS°-L-lysine4° (GL)  mol wt  ~40,000  (Miles  Laboratories Inc., Elkhart, IN)  were 
dissolved in 1% bicarbonate-buffered saline and subsequently adjusted to pH  7.0-7.4.  Oval- 
bumin (OVA) (Miles Laboratories Inc.) and keyhole limpet hemocyanin (KLH) (Calbiochem- 
Behring Corp., San Diego, CA) were dissolved in phosphate-buffered saline, pH 7.2-7.4. 
T Cell Hybridoraas.  T  celt hybridomas were derived as previously described (30). Briefly,  in 
vivo primed,  in  vitro  restimulated T  cell blasts were  fused  via polyethylene glycol to  the 
azaguanine-resistant AKR  thymoma  BW5147  and  hybrids were  selected  by  culture with 
hypoxanthine, aminopterin, and thymidine. Ag-specific,  I region-restricted hybrids were iden- 
tified on the basis of their ability to produce interleukin 2 (IL-2) upon antigenic stimulation as 
described by Kappler et al.  (22)  and as detailed below.  The T  cell hybridomas used in this 
report are shown in Table [. All hybrids were passaged in vitro in Dulbecco's modified Eagle's 
media (Gibco Laboratories, Grand Island, NY) with 4.5 g glucose per liter, 10% heat-inactivated 
fetal calf serum, and antibiotics. 
2  Animals used in this study were maintained in accordance with the guidelines of the Committee on 
Animals of the  Harvard  Medical School and those prepared by the Committee on Care and Use of 
Laboratory Animals of the Institutes of Laboratory Animal Resources, National Research Council (DHEW 
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Monoclonal Antibodies.  Monoclonal antibody from the hybridomas MKD6  (22)  (a-I-Ad, a 
gift from Dr. J.  Kappler and  Dr. P.  Marrack, National Jewish  Hospital, Denver, CO)  and 
10.2.16  (31)  (a-I-A  k, made available by Dr. L. A. Herzenberg, Stanford University, Stanford, 
CA) was purified from culture supernatant by affinity chromatography on protein A-Sepharose. 
Culture supernatant from HO2.2ADH4  (32)  (aLyt 2.2, made available by Dr. P. D. Gottlieb, 
University of Texas, Austin, TX) and purified HO13.4 (33) (a-Thy-1.2, made available by Dr. 
M. Gefter, Massachusetts Institute of  Technology, Cambridge, MA) were prepared as previously 
described (34). 
Cell Culture.  T cell hybridomas were stimulated in microculture as described by Kappler et 
al_ (22).  An optimal number of T  cell hybrids (2.5-10 X  104) were cultured in duplicate or 
triplicate in the presence or absence of Ag and/or accessory cells, in  200  /~1 of RPMI  1640 
(M.  A.  Bioproducts, Walkersville, MD)  supplemented  as  previously described  (34)  in  flat- 
bottomed microtiter wells (Falcon 3072;  Falcon Labware, Becton, Dickinson & Co., Oxnard, 
CA) for 20-26 h at 37°C. Spleen cells were exposed to  1660 rad gamma irradiation and used 
as a source of accessory cells. In some experiments the accessory cells were depleted of T cells by 
exposure to 400 ~g/ml of ammonium sulfate-purified monoclonal a-Thy-l.2 (HO  13.4) and  1 
ml a-Lyt-2.2 culture supernatant  (HO 2.2 ADH4) per 108 cells for 30 min at 0°C followed by 
incubation with 1 ml of a  l:6 dilution of rabbit complement (Low Tox; Accurate Chemical & 
Scientific Corp., Westbury, NY)  at  37°C  for 30 rain. Where indicated, the cloned, in vitro 
passaged, Ia-positive A-20 B lymphoblastoid line was used for a source of clonal accessory cells. 
This BALB/c cell line was originally isolated by Dr. Richard Asofsky (35) and has been shown 
to be a potent source of Ag-presenting cells (36, 37);  it was kindly provided by Dr. J. Kappler 
and Dr. P. Marrack (National Jewish Hospital). 
Antigen pulsing was accomplished by incubating 2 ×  107 spleen cells/ml in  17 ×  100-mm 
Falcon tubes or  106 A-20 cells/ml in macrowells with the indicated concentration of Ag in 
complete RPMI media for the indicated time at 37°C. Subsequently, the Ag-pulsed ceils were 
washed three times and the splenocytes were irradiated. Preparation of trinitrophenyl (TNP)- 
pulsed accessory cells was performed as previously described (38).  The number of accessory 
cells added to culture is shown in the respective experimental protocols. 
IL-2 Assay.  T  cell hybridoma activation was determined by measurement of the lympho- 
kine IL-2, as modified from the methods of Kappler et al, (22) and Gillis et al. (39) as previously 
described  (34).  Briefly,  100  /~1  of culture  supernatant  was  harvested,  exposed to  8,000  rad 
gamma irradiation and in some cases diluted with culture media. IL-2 content was measured 
by adding 5 X  103 IL-2-dependent cells (L2.2  [34] or HT2  [22])  and incubating for 20-26 h 
with  1 ~Ci of tritiated thymidine added over the last 4-6 h. Cultures were harvested on glass 
fiber filter strips with the aid of a semi-automated cell harvester (PHD cell harvester; Cambridge 
Technology Inc., Cambridge, MA) and the incorporation of label into DNA determined by 
scintillation counting. Except where noted, the concentration of IL-2 measured in the culture 
supernatant was limiting. 
Results 
Specificity  of MHC-restricted  GAT-specific  T  Cell  Hybridomas.  Our  laboratory  has 
recently derived a  series of MHC-restricted T  cell hybridomas with specificity for the 
Ir gene-controlled terpolymer GAT by fusing Ag-stimulated proliferating T  cell blasts 
with the AKR  thymoma, BW5147,  as modified from Kappler et al.  (22,  30).  As we 
have  previously shown  and  as is illustrated for a  representative hybrid in Table II, 
experiment  1,  the hybrids can be activated to produce the lymphokine IL-2  (T cell 
growth factor) after stimulation with GAT and syngeneic irradiated spleen cells as a 
source of accessory cells. No IL-2 is produced constitutively or by antigenic stimulation 
alone.  As  further  illustrated  in  Table  II,  experiments  2  and  3,  the  T  cell hybrid/ 
accessory  cell  interaction  is  H-2-restricted  and  is  inhibited  by  monoclonal  ~-I-A 
antibody, as we have previously described (30). 
We have recently shown  that  unmodified Ia determinants can make a  substantial ROCK  AND  BENACERRAF  1621 
TABLE  II 
MHC and Nominal Antigen Specificity of a Representative BALB/c  X  BW5147 GA T-selected T Cell 
Hybrid 
Accessory Cell*  Monoclonal  Antigen§  CPM ±  SEMI[ 
Experi-  Hybrid  antibody:~ 
ment  Strain  H-2 
1  RF9.140 
2  RF9.140 
3  R F9.140 
4  RF9.140 
....  148 +_ 18 
--  --  --  GAT  238 ±  14 
BALB/c  H-2  d  --  --  183 +  16 
BALB/c  H-2  d  --  GAT  27,973  +  415 
D2GD  H-2  ~  --  --  313  +  43 
D2GD  H-2  ~  --  GAT  37,637  ±  610 
BALB/c  H-2  a  --  --  262 ±  47 
BALB/c  H-2  d  --  GAT  22,728  ±  636 
C57BL/10  H-2  b  --  --  247 ±  10 
C57BL/10  H-2  b  --  GAT  395 ±  50 
BALB/c  H-2  d  --  --  626 ±  49 
BALB/c  H-2  d  --  GAT  15,516 ±  376 
BALB/c  H-2  d  a-LA  d  GAT  898 ±  88 
BALB/c  H-2  d  a-I-A  k  GAT  t5,756 ±  18 
BALB/c  H-2  d  --  GAT  19,919 
BALB/c  H-2  d  --  GA  928 
BALB/c  H-2  d  --  GT  1,155 
BALB/c  H-2  d  --  GA +  GAT  21,872 
BALB/c  H-2  d  --  GT +  GAT  1,962 
....  1,486 
Microcultures were prepared with 5 ×  104 cell hybrids with or without the indicated additions in a final 
volume of 0.2  ml  and cultured  at  37°C  for 20-26  h  after which time supernatant  was  removed, x- 
irradiated, and tested for IL-2 content as described in Materials and Methods. 
* 106 x-irradiated splenocytes from the indicated strains were used as the source of accessory cells. 
25 #g/ml final concentration of affinity-purified monoclonal antibody from the MKD6 (a-LA  d) or 10.2.16 
(a-I-A  k) cell lines. 
§500 p.g/ml final concentration for each antigen. 
IICPM from an IL-2 assay on culture supernatant expressed as the arithmetic mean +  SE for triplicate 
cultures. Experiment 4 was performed in duplicate so SE are not given. 
contribution  to  the  triggering  of some  Ag-specific T  cell  hybridomas  (30).  We  were 
interested  in  further  exploring  the  role  of  nominal  antigenic  determinants  in  the 
interaction  with  Ia molecules  and  the T  cell receptor(s).  Thus  we tested  the effect of 
the  structurally  related  copolymers  GT  and  GA  on  the  activation  of GAT-specific,  I 
region-restricted  T  cell hybridomas.  As is shown  in Table  II, experiment  4, neither  of 
these  structurally  related  copolymers  can  activate  the  RF9.140  GAT-specific 
hybridoma.  However,  we  made  the  striking  observation  that  inclusion  of the  nonre- 
sponder  copolymer  GT  in  cultures  of RF9.140  with  GAT  and  syngeneic  accessory 
cells markedly  inhibited  the T  cell hybridomas'  activation. 
Specificity of the GT-mediated Inhibition  of T  Cell Hybrid Activation.  The  GT-mediated 
inhibition  of the GAT-specific  T  cell hybridomas'  activation  is reversible, as shown  in 
Fig.  1 for two  GAT-specific  I-Aa-restricted  T  cell hybridomas.  Thus  under  conditions 
where,  relative  to  GT,  CAT  is equimolar  or in only  slight molar  excess, inhibition  is 
complete.  However,  as the GAT  concentration  is increased,  the GT-mediated  inhibi- 
tion  is  completely  abrogated.  This  finding  strongly  argues  against  GT  inhibition 
arising  from  nonspecific  effects  (e.g.,  toxicity)  and  indicates  that  GT  appears  to 1622  SPECIFIC  ANTIGENIC COMPETITION  FOR  ACCESSORY  CELL  PRESENTATION 
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FIG.  1.  Presence of GT in culture inhibits the activation of GAT-specific hybrids in a  reversible 
manner. Microcultures were prepared with 5 X  104 T  cell hybrids with  106 x-irradiated splenocytes 
a  source of APC,  in the presence or absence of the indicated  concentration of GAT, with (O)  or 
without  (0)  100/zg/ml of GT in  a  final  volume of 0.2  ml. Supernatant was harvested after 24 h, 
x-irradiated and assayed for IL-2 content as described in Materials and Methods, and the results are 
presented  as  the  arithmetic  mean  of triplicate  cultures  -+  SEM.  (A)  Cultures  with  RF9.140,  a 
BALB/c ×  BW5147  GAT hybrid and BDF1 spleen cells.  (B) Cultures with RF7.24.3,  a BALB/c × 
BW5147 GAT hybrid with BALB/c spleen cells. 
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FIG.  2.  Copolymer inhibition of GAT-specific hybrid activation is specific  for GT. Microcultures 
were prepared as described in Fig.  1 with RF9.140  and BALB/c spleen, except that cultures were 
tested with the indicated concentration of GAT alone (0), or with or without GAT and the following 
copolymers: 100/zg/ml GT (--O--), 400 #g/ml GA.(- -O- -), I00 ~g/ml GA (l'-l), or 100/~g/ml GL 
(11) 
function  as a  competitive inhibitor.  All  GAT-specific I-Ad-restricted T  cell hybrids 
tested thus far (four of four) have shown this same pattern (data not shown). 
It is possible that inclusion of any amino acid copolymer in the hybridoma cultures 
could interfere with the T  cell hybrid activation. Thus, to further define the specificity 
of inhibition,  we tested the effect of the addition  in culture of either the copolymer 
GA or GL. As can be seen in Fig.  2, neither GA nor GL appreciably interferes with 
the activation of the hybrid RF9.140 nor cross-reacts with GAT. This lack of inhibition 
is observed even ifa fourfold higher concentration (/zg/ml) of GA (Fig. 2) or GL (data 
not  shown)  is  used.  Experiments  using  the  RF7,24.3  GAT-specific  hybrid  have 
confirmed these findings (data not shown). Thus the inhibition of the GAT response 
appears  unique  to  the  GT copolymer, and  is  unlikely  to  arise  solely from  general 
effects, e.g., related to the charge of the inhibitor. 
The experiments  presented  thus  far do not  distinguish  whether GT  is  a  general ROCK  AND  BENACERRAF  1623 
inhibitor or is in fact specific for the GAT response. GT might indeed interfere with 
some aspect of the T  cell/accessory cell/Ag interaction irrespective of the particular 
nominal  antigenic  specificity. To examine this  point  we performed several experi- 
ments.  First we verified that  GT inhibition  does not occur with hybridomas of an 
unrelated  nominal  antigenic  specificity. GT does not  inhibit  I-Ad-restricted T  cell 
hybridomas with specificity for ovalbumin (OVA)  (Fig. 3 A; the DO11.10 hybrid was 
a  kind gift of Kappler and Marrack), keyhole limpet hemocyanin (KLH)  (Fig. 3B; 
AODK10.4 also provided by Kappler and Marrack), and TNP (Fig. 3 C). In fact the 
responses are often higher when GT is added. As can be seen in Fig. 3, the responses 
of these hybrids are of lesser magnitude relative to GAT-specific hybrids; therefore, 
lack of inhibition cannot reflect a stronger, and hence less suppressible, response. In 
all cases parallel cultures with a GAT-specific hybrid showed inhibition by GT (data 
not  shown).  We  next  tested  the  effect of GT  upon  the  activation  of the  hybrid 
RF 10.14, a GAT-specific T  cell hybridoma we recently described (29) with specificity 
for both unmodified I-A  a and LA  d plus GAT, resulting in both autoreactive and Ag- 
specific activation (30). If the GT-mediated inhibition were unrelated to the nominal 
antigenic specificity, then it would be predicted that the RF10.14 hybrid should be 
completely inhibited. As can be seen in Fig. 4, the RF10.14.22 hybrid produces no IL- 
2 constitutively (group A) but is triggered partially by syngeneic accessory cells (group 
B)  and  maximally  by  syngeneic  accessory cells  with  GAT  (group  D).  We  have 
previously determined that both the Ag-specific and autoreactive activation use the 
same LA  d molecule (30). If GT is included in culture, the Ag-specific activation is 
completely abrogated (compare groups D  and E), but the autoreactive activation is 
not  (compare  groups  B  and  C).  This  experiment  indicates  that  GT  specifically 
interferes with the Ag-specific portion of the response to GAT and  is not  generally 
inhibitory. The data also have implications for the mechanism of the GT inhibition 
that will be discussed below. Thus, the GT-mediated inhibition is highly specific for 
I  I 
0  100  500 
.zig/m~ OVA 
0 
f 
[  I  I 
25  50  100 
//g/m/ KL  H 
 °tc 
I  I  t 
0  P.5  5  10 
TNP  Stimulators  x  I0  ~ 
Fzo.  3.  GT does not inhibit T  cell hybridomas of other nominal antigenic specificities. Microcul- 
5  d  5  tures were prepared with: (A)  10  DO11.I, an I-A -restricted, OVA-specific hybrid; (B)  10  AODK 
d  5  d  10.4,  an I-A -restricted,  KLH-specific hybrid or  (C)  10  RFI5.7,  an I-A -restricted, TNP-specific 
hybrid, and the indicated soluble Ag- or TNP-coupled BALB/c splenocytes in the absence (0) or 
presence (O)  of 100/zg/ml of GT, and handled as described in Fig.  1. 1624  SPECIFIC  ANTIGENIC COMPETITION  FOR  ACCESSORY  CELL  PRESENTATION 
BALBIc  _Ag in Culture 
Group.  Hybrid  APC  GT  GAT I 
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B  RFt0.14.22  + 
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FIG.  4.  GT inhibition is specific for the GAT-specific portion of the hybrid response. Microcuhures 
were prepared as described in Fig.  1, except using l0  s hybrids, BALB/c spleen, with or without 500 
~g/ml GAT and  100/~g/ml GT. RF10.14.22  is a clone of the RF10.14 BALB/c ×  BW5147 hybrid 
which is both autoreactive and Ag-specific  (30). 
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FTO.  5.  T  suppressor  cells  do  not  account  for GT-mediated  inhibition.  Cultures  were prepared 
with 5 X  104  RF7.24.3  cells  as described in Fig.  1, except that in (A) x-irradiated BALB/c spleen 
cells were either untreated (  ) or treated with a-0, ~-Lyt-2 +  complement (- - -); cultures were 
constructed with these two splenocyte populations with (O) or without (0)  100 #g/ml GT; and in 
(B) 2 ×  104 A20 tumor cells were substituted for splenic accessory cells; cultures were prepared with 
(O) or without (Q)  100 ~g/ml of GT. 
the GAT response. 
GT Inhibition  of GA T  Responses Is Not Due to  T  Suppressor Cells.  The copolymer GT 
is a nonresponder Ag in all inbred strains of mice. The basis for nonresponsiveness in 
some strains  (e.g., H-2  d) is due, at least in part,  to the indu.ction of suppressor T  cells 
(40, 41). The possibility must be envisaged that GT induces suppressor T  cells in the 
spleen  cells  used  as  a  source  of accessory  cells,  which  then  suppress  the  hybrid 
activation. This possibility is considered unlikely as the culture period is short and the 
splenocytes are irradiated.  However, to formally exclude this mechanism, we depleted 
the accessory cell population of T  cells by treatment with both monoclonal a-Thy-1.2 
and a-Lyt-2.2 antibody and complement.  As can be seen in Fig.  5 A, GT causes the 
same  degree  of inhibition  whether  or not  the  accessory cell  population  contains  T 
cells. Additionally, a  cloned source of accessory cells can be used in this system with ROCK AND BENACERRAF  1625 
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Flc. 6.  GT does not inhibit hybrid responses to OVA or KLH with A20 APC. 105 DO.11,10 
hybrids (A) or l0  b AODK 10.4 hybrids (B) were cultured with 2 ×  104 A20 cells and the indicated 
Ag concentrations in the absence (0) or presence ((3) of 100/~g/ml of GT. 
identical  results.  As  recently described,  Ia-positive B  lymphoblastoid cell  lines  can 
function to present Ag to MHC-restricted T  ceils (36, 37). As shown in Fig. 5 B, the 
H-2  d  B  lymphoblastoid  cell  line,  A-20,  is  a  potent  APC  in  our  system.  Further 
inclusion  of GT  in  the  cultures  of RF9.140  with  A-20  cells  and  GAT completely 
inhibits this response, and the inhibition is reversed by high concentrations of GAT. 
As illustrated in Fig. 6, the GT inhibition of GAT cultures with A-20 cells is specific, 
as neither an OVA- (Fig. 6 A) or KLH- (Fig. 6 B) specific response is inhibited by the 
presence of GT in culture.  Additionally,  mixing experiments with an OVA-specific 
hybrid and a  GAT-specific hybrid in the same culture with both relevent Ag shows 
no GT suppression of the OVA response (data not shown).  These experiments rule 
out the possible role of a suppressor T  cell or factor in this phenomenon. 
Localization  of the Inhibitory Effect of GT.  The experiments presented thus far indicate 
that GT, but not other related copolymers, specifically inhibits the activation of GAT- 
specific T  ceil hybridomas, and that T  suppressor cells are not involved. However, the 
locus of the inhibition is not defined. GT may compete with GAT either at the level 
of the APC  or at  the responding T  cell.  To distinguish  between  these  alternatives, 
experiments were performed where  either the  accessory cells or T  cell hybridomas 
were preincubated with GT and then tested for functional ability. As shown in Fig. 
7 A, if BALB/c accessory cells are pulsed with GAT for 18 h and subsequently washed 
to remove free Ag, they will function to activate RF9.140.  However, if GT is present 
during  the  preincubation  period,  there  is  marked  interference  with  effective  Ag 
pulsing,  which  is  partially  reversed  at  high  GAT  concentration.  In  our work,  Ag 
pulsing of splenocytes appears to be less efficient for subsequent presentation relative 
to the use of fresh splenocytes with soluble Ag. Thus the level of response under these 
conditions is smaller (compare Fig. 7 A with Figs.  1 and 2). We therefore repeated this 
experiment using the A-20  Ag-presenting B  lymphoblastoid line.  As shown  in  Fig. 
7 B, preexposure of A-20 cells to GAT results in excellent Ag presentation. If however 
the A-20 cells are pulsed with both GAT and GT, the ability to present Ag is markedly 
inhibited,  although high concentrations of GAT reverse this inhibition.  This pattern 
is identical to that described above in experiments where GT was added directly to 
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Fro.  7.  GT inhibits Ag pulsing of APC. Microcultures  were prepared with 5 X  104 RF9.140 cells 
as described  in Fig.  t except  that  all the Ag present  in culture was introduced on Ag-prepulsed 
accessory cells. Accessory cell populations were exposed  to the indicated concentration of GAT for 
18 h with (O) or without (O)  I00/.tg/ml of GT, washed extensively, and added to culture. (A) 106 
x-irradiated  BALB/c Ag-pulsed splenocytes;  (B)  2  ×  10  '~ Ag-pulsed  A20 B  lymphoblastnid cells. 
With the maximal response, the amount of IL-2 measured in this assay was not limiting (data not 
shown). 
TABLE III 
Effect  of Related Copolymers on Antigen  Presentalion  by A20 Cells 
APC  antigen-pulsil~g conditions 
A-20  #g/ml  Antigen in  CPM  ±  SEM 
Group  Hyblid  APC  25/~g/ml  100 lag/  100 #g/  ct,ltu,'e 
C;AT  ml GT  ml GL 
A  RF9.140  +  ....  568 ~  55 
B  RF9.140  +  +  -  -  --  28.637 ±  1,201 
C  RF9.140  +  +  +  -  --  t137  ±  12 
D  RFg. 140  +  -  +  -  -~  615 +  19 
E  RFg. 140  +  --+t  Mixed  t:  --  --  3t,287--+  1,200 
F  RF9.140  +  +  -  +  --  27.795 -+  234 
G  RFg. 140  +  -  -  +  --  41(:,  -+  198 
H  RF9.140  +  -  --  -  I0O GAT  42,451  ±  582 
I  RF9.140  +  -  +  -  100 (;AT  37A68 -+  1,532 
J  R F9.140  +  -  -  3  (;AT  I L371  -+ 56 
K  RF9.140  +  -  +  -  3 GAT  2,803 -+ 613 
L  RFI5.7  +  -  -  -  647 ±  69 
M  RFI57  +  --  --  TNP  10 mM  4.245 ±  486 
N  RF157  +  --  +  -  --  550 -+ 4 
O  RF[57  +  --  +  --  TNP  10 mM  1,013 +  42t 
Microcultures were prepared with 5  ×  10  a (RFg. 140)  or  l0  s  (RFI 5.7)  T  cell hybtid~ and  2 ×  104 Ag-ptdscd or tmpulscd A20 B lymphoblastoid 
cells as a  clona] source of APC, with or without soluble GAT  in 0.2 ml and handled as dcscrihcd in TaMe II Group E  cor~tained 2 X  104 each 
of GAT-pulsed  and GT-pulsed A20 cells. 
The inhibition that is seen by preexposure  of the accessory cell to GT is specific.  As 
shown  in Table  III,  pulsing A-20  cells with  GT  but  not  GL  causes  an  inhibition  of 
subsequent Ag presentation.  Preexposure  of A-20 cells solely to GT does not inactivate 
these cells since they are capable of presenting soluble GAT  if high concentrations are 
used (Table III); such prepulsed cells efficiently present TNP  to a TNP-specific  hybrid 
(Table  III).  Also,  GT  does  not  inhibit KLH  pulsing of A-20 APC  (data  not  shown). 
If GT-prepulsed  A-20  cells are tested  at  more limiting GAT  concentrations,  they are 
partially  blocked  in  their  ability  to  present  GAT  (Table  ]II)  indicating  that  preex- 
posure  to  GT  alone  is  sufficient  to  cause  the  inhibitory  effect  although  it  is  more 
easily reversed. 
The  reciprocal  experiment  where  the  T  cell  hybridoma  is  preincubated  with  GT ROCK  AND  BENACERRAF  1627 
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FIo.  8.  T  cell  hybridomas are not sensitive to preexposure to GT. Microcultures were prepared 
with 106 x-irradiated BALB/c splenocytes and (A) 5 ×  104 RF9.140 or (B) 5 ×  104 RF7.24.3 cells as 
described in Fig.  1, except hybrids were prepulsed with media (0) or 100/~g/ml GT (C)) for 18 h at 
37°C, washed, and tested in cultures. 
TABLE  IV 
APC Antigen-pulsing Conditions 
Experi-  Hybrid  A20 APC  Antigen  GT in  CPM +  SEM 
ment  culture 
1  RF9.140  +  --  -  876 ±  96 
+  GAT  -  13,160 ±  546 
+  GAT  +  2,636 ±  152 
AODK10.4  +  --  -  643 ±  112 
+  KLH  -  2,305 ±  83 
+  KLH  +  4,574 +_ 93 
2  RF9.140  +  --  -  869  ±  58 
+  GAT  -  19,318 ±  103 
+  GAT  +  4,902 ±  733 
D011.10  +  --  -  789 :lz 213 
+  OVA  -  9,824 ±  729 
+  OVA  +  8,794 ±  97 
Microcultures were prepared with 5 x  104 (RF9.140)  or l0  n (AODK10.4 and DO11.10) hybrids with 5 × 
104 Agopulsed or unpulsed A20 cells and 100 ~g/ml GT where indicated, and were otherwise handled as 
described in Table II. A20 cells were pulsed for 18 h  with either 10 #g/ml GAT or 250 #g/ml KLH or 
OVA; all of which are limiting Ag concentrations for pulsing (data not shown). 
for  18 h, washed, and subsequently  tested in culture is shown in Fig. 8. Preincubation 
of the T  cell hybrids  does not cause inhibition. This indicates that the mechanism  of 
inhibition  is not caused by the interaction of free Ag with the T  cell hybrids. Further, 
the inhibition that is seen by prepulsing the APC  cannot  be attributed  to the paralysis 
of the T  cell hybridoma  from carry-over of antigen.  These experiments  indicate  that 
GT  preexposure  of the accessory cell but  not  the T  cell hybridoma  is both  necessary 
and  sufficient to produce  the GT-inhibitory  effect. 
We  next tested the effect of GT  upon  GAT  presentation  by GAT-prepulsed  APC. 
Thus,  A20 cells were Ag-pulsed for 18 h, a  sufficient time for Ag uptake  and processing 
(unpublished  data)  and  were  then  tested  for  their  ability  to  present  GAT  in  the 
absence  or  presence  of  GT  in  culture.  As  shown  in  Table  IV,  GT  inhibits  the 
activation of the T  cell hybrid  to GAT-prepulsed  APC. This effect is specific, as KLH- 
or OVA-prepulsed  APC  are  not  inhibited  by  the addition  of GT  to  culture  (Table 
IV). The  most efficient inhibition however occurs if GT  is present at the time of GAT 1628  SPECIFIC  ANTIGENIC COMPETITION FOR ACCESSORY CELL PRESENTATION 
pulsing  (Fig, 7). 
It is possible that inhibition  of presentation  at the level of the accessory cell could 
arise  from either GT competition with GAT for association  in the  accessory cell  or 
from GT independently associating with the accessory cell and subsequently compet- 
ing  for  I-A plus  GAT  recognition  by  the  T  cell.  According to  the  latter  scheme, 
inhibition would result from a decrease in the number of appropriate receptor/ligand 
interactions or by imparting a  negative signal to the T  cell. As shown in Table III, if 
GT-pulsed accessory cells are mixed with GAT-pulsed accessory cells, no inhibition is 
seen.  Since the cultures should contain the same number of "inappropriate  ligands", 
if independent,  it is unlikely that GT mediates its inhibition as a  direct consequence 
of independent  associative recognition. The experiment  with the GAT-specific auto- 
reactive  T  cell  hybridoma  described  above  (Fig.  4)  also  strongly  argues  against 
independent recognition of GT resulting in a negative signal to the T  cell hybridoma. 
Thus the mechanism of GT-mediated inhibition of the GAT response appears to most 
likely reflect a  competition of GT for GAT association at the APC. 
Relation of GT Inhibition to MHC-restriction  Specificity: Effect of aT Upon Presentation by 
I-A uxd F1 APC.  We have previously described T  cell hybridomas with specificity for 
GAT in association with I-A  u (30).  Preliminary experiments  revealed that several of 
these  hybrids  were  not  inhibited  by GT  using  C57BLt0  accessory  cells  (data  not 
shown). We therefore tested the effect of GT upon both RF9.140  (restricted  to I-A  a) 
and  RFI3.64  (restricted  to LA  b)  using H-2  d X  H-2  u F1  accessory cells.  As shown in 
Fig.  9, RF13.64  is not  inhibited  by the inclusion  of GT in culture  (B  and  D)  while 
under identical  conditions, the  RF9.140 hybrid is inhibited  (A and C). This experi- 
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Fro.  9.  GT  inhibits an  [-Aa-restricted  but  not  I-Ab-restricted OAT  hybrid.  Microcu[tures  were 
prepared as described in Fig, 1 with 5 X L04 RF9.140 (A and C) and 10  ~ RF13,64 (B and [3). Two 
representative experiments are shown: experiment 1 (A and B); Experiment 2 (C and D). Cultures 
were constructed with i0  ~ x-irradiated CBF, splenocytes, with (Q)) or without (0)  L00 #g/ml of GT. 
RF9.I40 is a BALB/c × BWbL47 hybrid and RFL3.64 is a C57BL/10 X BW5147 hybrid. ROCK  AND  BENACERRAF  1629 
ment strongly suggests that the GT-mediated inhibition cannot be accounted for by 
nonspecific inhibition of the accessory cells.  Furthermore, GT is unlikely to exert its 
inhibition through a general interference with accessory cell Ag uptake or processing 
because if this occurred, the F1 accessory cell should not be able to present GAT to 
RF13.64. 
Discussion 
These experiments were undertaken to analyze the interaction of nominal Ag with 
accessory cells and/or the T  cell receptor(s). We chose the Ag GAT and its related 
copolymers because they are simple Ag, composed of only two to three amino acids, 
and are under control ofMHC-linked Ir genes. The model system selected was an Ag- 
specific, MHC-restricted T  celt hybridoma/accessory cell interaction in which c]onal 
populations of all interacting partners could be used. The major findings of this report 
are: (a) Multiple H-2-restricted GAT-specific T  cell hybridomas fail to respond to the 
related  copolymers  GA  and  GT.  (b)  The  nonresponder  copolymer GT  markedly 
inhibits the response of BALB/c, I-Ad-restricted, but not B10, I-Ab-restricted, GAT- 
specific T cell hybridomas to GAT plus accessory cells. (c) The GT-mediated inhibition 
of hybridoma activation is specific, only occurring with the GAT response. (d) Other 
structurally related, similarly charged  copolymers fail  to  block the hybridoma re- 
sponse.  (e)  The GT-mediated inhibition  occurs at  the  level  of the  APC.  (f)  The 
inhibition is reversible. (g) GT can inhibit presentation by GAT-prepulsed APC. (h) 
This  specific  competition  suggests  a  specific  interaction  of Ag  with  APC.  Initial 
experiments tested whether MHC-restricted T cell hybridomas with specificity for the 
terpolymer GAT would cross-react with either of the two GAT-related copolyrners, 
GA or GT. A  series of BALB/c-derived, GAT-specific, I-Ad-restricted hybrids were 
thus  tested  and  no  cross-reactions  were  detected.  The  data  does  not  distinguish 
whether GT/GA nonresponsiveness occurs because the hybrids are specific for a GAT 
determinant or because they are specific for GA or GT but fail to respond because the 
simpler GAT-related copolymers are not presented appropriately. Whatever the case, 
this lack of cross-reaction allows the related copolymers to be tested for their potential 
to act as competitive inhibitors. Thus if either of the related copolymers competes for 
GAT association at the T  cell's receptor(s) or for presentation by the accessory cell, 
then  under  limiting conditions  it  should  inhibit  the  GAT-specific T  cell hybrid's 
activation. 
The potential for cross-inhibition in the hybrid system was tested by the addition 
of related copolymers to GAT cultures. Inclusion of GT in cultures of BALB/c GAT- 
specific T  cell hybridomas markedly inhibited the response to GAT. This inhibition 
is  not  caused  by  an  excess  of amino  acid  copolymers in  culture,  as  GAT  is  not 
inhibitory even at very high concentration (Fig.  1) and the inhibition can be reversed 
by increasing the concentration of  GAT (Fig. 1). The inhibitory effect appears specific 
for the GT copolymer insofar as both GA and GL, even in excess, are without effect. 
Several experiments indicate that  the GT-mediated inhibitory effect is  selective. 
Inhibition  is  seen  with  several  BALB/c  GAT-specific  T  cell  hybridomas.  These 
hybrids arose from three independent fusions and are therefore unlikely to represent 
an  unusual  or fortuitous phenotype. In  contrast, hybrids with  specificity for other 
protein Ag in association with  I-A  d,  namely OVA and  KLH, are not  inhibited by 
GT. In addition, two independently derived BALB/c TNP-speeific hybrids (Fig. 3 C 1630  SPECIFIC  ANTIGENIC COMPETITION  FOR ACCESSORY CELL PRESENTATION 
and data not shown) are not inhibited by inclusion of GT in culture. Furthermore, we 
tested a GAT-specific hybridoma that autoreacts to unmodified LA  d alone, albeit to 
a  lesser degree, and found that only the nominal Ag-specific portion of the response 
was inhibited.  Taken together these results show that GT inhibition of the BALB/c 
GAT  hybridomas  is  highly  specific for nominal  antigenic  activation  of hybrids  in 
association with I-A  d on APC. The finding of specific competitive inhibition suggests 
that there is an inhibitable locus of specific Ag association. 
To localize the site of inhibition,  APC or hybrids were preincubated with Ag and 
tested  for  subsequent  function.  As  expected,  exposure  of APC  to  GAY  results  in 
successful  'pulsing'  for subsequent  presentation.  Successful  pulsing  is  however,  in- 
hibited by GT. Higher concentrations of GAT reverse the inhibition,  paralleling the 
findings above and arguing against toxic effects. Also GT does not interfere with KLH 
pulsing (data not shown) and GT-pulsed accessory ceils are fully competent to present 
unrelated  Ag, e.g., TNP  (Table III) and OVA (data not shown). Additionally, GT- 
pulsed accessory cells are not  inhibitory to separately GAT-pulsed cells  (Table III). 
On the other hand, if the T  cell hybridomas are prepulsed with GT, from  I to  18 h 
before culture,  no inhibition  ensues.  Taken together these  findings localize the GT 
inhibitory effect to the APC. 
The localization of inhibition to the level of the accessory cell suggests but does not 
establish  that  GT  specifically  competes  for  GAT  association  with  the  APC.  The 
alternative, that GT independently associates with the accessory cell and interferes by 
creating an impotent or tolerizing independent determinant or even by the generation 
of suppressor cells is highly unlikely based on several experiments. First, co-culture of 
separately pulsed GT and GAT-APC should cause inhibition if inappropriate deter- 
minants  interfere  with  the  appropriate  receptor/ligand  interaction,  which  is  not 
observed. Next if GT formed an independent toleragenic determinant, then the GAT- 
specific autoreactive hybrid, RF10.14, should be totally inhibited, which also was not 
observed. Finally, T  suppressors were ruled out by negative selection and use of clonal 
APC, and nonspecific suppressive effects were not detected in mixing experiments. 
All  BALB/c-derived, GAT-specific T  cell  hybridomas thus  far examined  (four of 
four, from three independent  fusions) demonstrate the phenomenon of GT-mediated 
inhibition  (Figs.  I,  4,  and  data  not  shown).  It  is  possible  however,  that  some 
noninhibitable clones might be found as larger numbers of hybrids are examined. In 
contrast, preliminary studies of several B 10-derived GAT-specific hybrids suggest that 
most of these  (four out of five) are not inhibited  by GT  (work in progress). One of 
these  B10  hybrids  was  tested  with  I-A  bXd  F1 APC  and  showed  no  GT  inhibition 
whereas parallel cultures with a BALB/c hybrid were inhibited  (Fig. 9). The mecha- 
nism underlying this differential effect of GT on these two hybrids is not defined by 
the present data. One possibility is that the selective inhibition relates to the restriction 
element  recognized  by the T  cell  hybridoma. Thus,  it  is possible that  the  locus of 
inhibition is a site associated with the APC's I-A molecule and that the I-Ab-assoeiated 
site interacts with GAT via a different determinant or with different affinity than the 
I-An-related site.  Models have previously been proposed that postulate such specific 
Ag association with Ia molecules (23, 29). According to this scheme, the finding of an 
I-Ab-restricted hybrid that  is  inhibited  by GT would  suggest  that  a  particular  I-A 
molecule  could  have  more  than  one  distinct  Ag-association  site.  An  alternative 
possibility is that the differential inhibitory effect reflects differences in the respective ROCK AND  BENACERRAF  1631 
T  cell hybridomas.  Thus,  noninhibited  hybrids of BI0 origin might  differ in  their 
specificity, e.g., they might be of higher affinity. It should be noted however, that the 
Ag dose-response curve is similar between the two sets of hybrids (Fig. 9). The data 
does not distinguish among these possibilities and subsequent experiments will focus 
on these issues. 
The precise site of specific association and competition at the APC has not been 
identified.  For successful presentation,  an  APC  must  acquire Ag  and  further may 
need  to  'process'  it  (42-44).  Additionally,  there  may  be  an  interaction  between 
nominal Ag and MHC molecules as has been suggested from analysis of the MHC 
and  Ir gene effects upon  the fine specificity of T  cell responses  (23-26).  GT could 
potentially compete with GAT at any or all of these steps. Whether MHC molecules 
participate in APC Ag uptake, processing or Ag orientation, or whether any of these 
steps are linked, is unknown. The experiment using I-A  b*d F1 APC however, suggests 
that GT is not simply competing for a  general uptake/processing mechanism  inde- 
pendent of MHC gene products; otherwise both I-A  b and I-A  d associative recognition 
should  be  inhibited.  Furthermore, GT causes  inhibition  of presentation  by GAT- 
prepulsed APC  (Table IV).  Since under these conditions, APC have taken up and 
processed Ag (as subsequent metabolic inhibition of such APC doesn't interfere with 
presentation; data not shown), the locus of GT inhibition is most likely not solely at 
either of these  points.  Taken  together,  the  data  are  most  consistent  with  a  direct 
inhibition  of GAT  association  at  the  level  of presentation.  We  have  previously 
proposed that Ag specifically associate with Ia molecules on APC  (29).  The data in 
this report support this hypothesis but do not directly demonstrate such an association. 
The ability to inhibit presentation by GAT-prepulsed APC would suggest  that  the 
association is noncovalent. 
This capacity of accessory cells to specifically associate with an Ag should occur 
through  an  Ag-recognition site  that  is  not  clonally distributed,  in  contrast  to  the 
lymphocyte  (45),  because  a  clonal  source  of APC  can  present  multiple  Ag.  We 
speculate that other structurally distinct Ag use other recognition sites, a notion that 
is supported by recent studies of antigenic competition in the guinea pig (46). The 
methods described in this paper may serve as a general approach to define the nature 
of such other sites. As a practical consideration, the ability of related Ag to compete 
for association should depend on their relative affinity. In our system GT appears to 
be a  very efficient inhibitor giving complete inhibition at less than equimolar ratios 
and furthermore is effective even if prepulsed. It is possible that GT associates more 
avidly,  although  this  is  speculative.  Since GT is  nevertheless a  nonresponder Ag, 
nonresponsiveness may occur in spite of molecular interactions between Ia and Ag. 
Such nonresponsiveness may then result from the inability of the T  cell receptor to 
properly interact with the complex or its components. 
Summary 
The interaction of nominal  Ag  with  major histocompatibility complex  (MHC)- 
restricted T cells and accessory cells was studied by analyzing the effect of structurally 
related antigens on the response of  antigen-specific MHC-restricted T cell hybridomas. 
The copolymer L-glutamic acidS°-L-tyrosine  5° (GT) completely inhibits the response 
of L-glutamic acidn°-L-alanine4°-L-tyrosine  x° (GAT)-specific, I-An-restricted T  cell hy- 
bridomas  to GAT plus accessory cells. This inhibition is specific, as hybridomas of 1632  SPECIFIC ANTIGENIC COMPETITION  FOR ACCESSORY  CELL  PRESENTATION 
other specificities are not  inhibited under identical conditions, and is unique  to the 
GT  antigen, as other similar copolymers are not  inhibitory. The  inhibitory effect is 
reversible by adding increasing amounts of GAT. Antigen-pulsing experiments local- 
ized the inhibition to the level of antigen-presenting cell (APC). GT-prepulsed APC 
are not inhibitory in cell-mixing experiments and can present other antigens. GT only 
inhibits  the  nominal  antigen-directed  component  of a  GAT-specific, autoreactive 
hybrid's  response.  Together  these  findings  suggest  that  GT  causes  inhibition  by 
competing  for  GAT  association  at  the  accessory  cell.  GT  interferes  with  GAT 
presentation by an  I-A  dxb F1 APC  to a  BALB/c, I-Ad-restricted, but  not  B10, LA  b_ 
restricted, T  cell hybridoma, and GT inhibits presentation by GAT-prepulsed APC. 
The  implications of these  findings  for  MHC-restricted presentation  of antigen  are 
discussed. 
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